pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

15,048 catalysts · 3,603 8k filing · 2,723 grant · 2,426 approval · 1,714 device 510k · 1,264 device recall · 1,172 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 30 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2025-09-29×clear all
type
  • 8k filing3,603
  • grant2,723
  • approval2,426
  • device 510k1,714
  • device recall1,264
  • device pma1,172
device adverse event
1,000
  • earnings585
  • recall481
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Sep 29, 2025

    50
    ›Sep 29, 2025grant334d agoUnknown institution — TASK ORDER AWARD. CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES ...

    DA grant. $56,100

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoLEIDOS BIOMEDICAL RESEARCH, INC. — CHARACTERIZATION OF MPOX

    AI grant. $5,583,900

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — MEDICINAL CHEMISTRY CONSULTING SERVICES.

    DA grant. $7,840

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoPRINCETON UNIVERSITY — Light-Driven Deracemization of Atropisomers Enabled by Chiral Photocatalysts

    GM grant. $74,632. PI: Nicodemo Ciccia

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoCHILDREN'S HOSP OF PHILADELPHIA — Genomic and exposomic factors in the cause and rise of autism

    OD grant. $4,314,261. PI: Whitney Guthrie

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoJOHNS HOPKINS UNIVERSITY — Boston Birth Cohort - Autism Data Science Initiative (BBC-ADSI)Johns Hopkins University

    OD grant. $3,861,440. PI: Alexis Battle

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Modeling autism-associated gene-by-environment interactions in human brain or...

    OD grant. $3,934,201. PI: Joseph Piven

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoDREXEL UNIVERSITY — Diet and the exposome in autism: Discovering complex interactions with diet i...

    OD grant. $2,028,527. PI: KRISTEN Lyall

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUNIVERSITY OF MINNESOTA — Mechanisms of adipose tissue functional decline with aging.University of Minnesota

    AG grant. $36,751. PI: In Hwa Jang

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoSTANFORD UNIVERSITY — Toward the Precision Diagnosis and Prevention of Acquired and Congenital Long...Stanford University

    HL grant. $80,224. PI: Michael Bon-Hao Liu

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Implementing lifestyle change interventions to improve health outcomes

    DP grant. $492,348. PI: Charles Richard Jonassaint

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — PHARMACEUTICS FORMULATION/CHEMISTRY MANUFACTURING AND CONTROLS CONSULTING SER...

    DA grant. $8,460

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — PHARMACEUTICS FORMULATION/CHEMISTRY MANUFACTURING AND CONTROLS CONSULTING SER...

    DA grant. $10,000

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — TASK ORDER AWARD. CHEMISTRY, MANUFACTURING AND CONTROLS AND RELATED SERVICES ...

    DA grant. $45,200

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — MEDICINAL CHEMISTRY CONSULTING SERVICES.

    DA grant. $12,000

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoOHIO STATE UNIVERSITY — WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A2

    HL grant. $38,666. PI: REBECCA JACKSON

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUNIVERSITY OF FLORIDA — Procession to IND of a capsid mutated AAV8 codon optimized NAGLU vector for t...University of Florida

    NS grant. $538,939. PI: BARRY J BYRNE

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoBOSTON CHILDREN'S HOSPITAL — Integrating Genetic and Environmental Data to Predict Autism Susceptibility a...Boston Children's Hospital

    OD grant. $4,249,149. PI: Wendy K Chung

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUNIVERSITY OF CALIFORNIA, SAN DIEGO — Elucidating the Interplay of Genes and Environment in Autism Using Genomic an...University of California San Diego

    OD grant. $3,938,148. PI: Jonathan Sebat

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Data science approaches to autism: environmental modulators of the transcript...University of California Los Angeles

    OD grant. $4,255,873. PI: DANIEL H GESCHWIND

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoCOLLABORATIONS PHARMACEUTICALS, INC. — Discovery and Development of Oral Small-molecule Direct-acting AntiviralsCollaborations Pharmaceuticals Inc

    AI grant. $1,999,195. PI: SEAN EKINS

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoBIOTEAM, INC. — NIMHD SCHARE RESEARCH PLATFORM:SCHARE-TERRA-GDE

    HD grant. $225,000

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — MEDICINAL CHEMISTRY CONSULTING SERVICES.

    DA grant. $21,150

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — BIOACTIVITY ASSAY DEVELOPMENT CONSULTING SERVICES

    DA grant. $12,421

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoRESEARCH TRIANGLE INSTITUTE — NHLBI CATALYZE COORDINATING CENTER - PRODUCT DEVELOPMENT SUPPORT SERVICES, TA...

    HL grant. $1,999,671. PI: Hendree E Jones

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoRESEARCH TRIANGLE INSTITUTE — NHLBI CATALYZE PRECLINICAL SERVICES: PROJECTS YR. 4 - TASK ORDER 5

    HL grant. $9,999,898. PI: Hendree E Jones

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoUnknown institution — Discovery and Development of Oral Small-molecule Direct-acting Antivirals for...

    AI grant. $498,199. PI: JUAN PIZARRO

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoDIGITAL INFUZION, INC. — THE SCOPE OF THIS PROCUREMENT IS TO DEVELOP, REFINE, DEPLOY, VALIDATE, MAINTA...

    OD grant. $3,804,755. PI: KAREN A. STARK

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Exploring a role for mPFC CRF circuitry in promoting stress-enhanced alcohol ...

    AA grant. $49,538. PI: Kathryn Anne Carter

    full page →nih reporter ↗
    ›Sep 29, 2025grant334d agoBOSTON CHILDREN'S HOSPITAL — Metagenomic Profiling of Dust Samples for School-based Viral SurveillanceBoston Children's Hospital

    AI grant. $90,946. PI: Ye Sun

    full page →nih reporter ↗
    ›Sep 30, 2025approval333d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: AMNEAL. Form: TABLET. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Sep 30, 2025approval333d agoTRAMADOL HYDROCHLORIDE — FDA approvaltramadol hydrochloride ER

    Sponsor: MYLAN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →tramadol hydrochloride ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoMIFEPREX (MIFEPRISTONE) — FDA approvalCORCEPT THERAPEUTICS INC

    Sponsor: DANCO LABS LLC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoQULIPTA (ATOGEPANT) — FDA approvalatogepant

    Sponsor: ABBVIE. Form: TABLET. Route: ORAL

    full page →atogepant →fda approvals ↗
    ›Sep 30, 2025approval333d agoMIFEPRISTONE — FDA approvalMIFEPRISTONE

    Sponsor: GENBIOPRO. Form: TABLET. Route: ORAL

    full page →MIFEPRISTONE →fda approvals ↗
    ›Sep 30, 2025approval333d agoOLANZAPINE — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalMacleods Pharmaceuticals Ltd

    Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoIRBESARTAN — FDA approvalIRBESARTAN

    Sponsor: HETERO LABS LTD V. Form: TABLET. Route: ORAL

    full page →IRBESARTAN →fda approvals ↗
    ›Sep 30, 2025approval333d agoVORICONAZOLE — FDA approvalGreenstone LLC

    Sponsor: NOVEL LABS INC. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoOLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoTEGRETOL-XR (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ACTAVIS ELIZABETH. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Sep 30, 2025approval333d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: STRIDES PHARMA. Form: CAPSULE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Sep 30, 2025approval333d agoTEGRETOL (CARBAMAZEPINE) — FDA approvalcarbamazepine ER

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →carbamazepine ER →fda approvals ↗
    ›Sep 30, 2025approval333d agoRHAPSIDO (REMIBRUTINIB) — FDA approvalremibrutinib

    Sponsor: NOVARTIS. Form: TABLET. Route: ORAL

    full page →remibrutinib →fda approvals ↗
    ›Sep 30, 2025approval333d agoMIFEPRISTONE — FDA approvalMIFEPRISTONE

    Sponsor: EVITA SOLUTIONS. Form: TABLET. Route: ORAL

    full page →MIFEPRISTONE →fda approvals ↗
    ›Sep 30, 2025approval333d agoTIZANIDINE HYDROCHLORIDE — FDA approvalRiconpharma LLC

    Sponsor: ALKEM LABS LTD. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Sep 30, 2025approval333d agoVORICONAZOLE — FDA approvalVORICONAZOLE

    Sponsor: MEITHEAL. Form: POWDER. Route: INTRAVENOUS

    full page →VORICONAZOLE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ›Sep 30, 2025approval333d agoCIPROFLOXACIN HYDROCHLORIDE — FDA approvalCIPROFLOXACIN HYDROCHLORIDE

    Sponsor: CHARTWELL. Form: TABLET. Route: ORAL

    full page →CIPROFLOXACIN HYDROCHLORIDE →fda approvals ↗
    ← prev
    page 2 of 301
    next →
    $ABBV259.04-1.47%
    $AMRX17.54-2.61%
    $NVS153.81-0.54%
    $CORT113.88-2.61%
    $NVS153.81-0.54%
    $NVS153.81-0.54%